{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T10:40:52Z","timestamp":1700131252218},"reference-count":18,"publisher":"Bentham Science Publishers Ltd.","issue":"8","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>This patent describes the series of compounds and their pharmaceutically acceptable\nsalts, such as compound K7 (as a representative potent compound). These protein\nkinase C selective inhibitors are useful for treating diabetes mellitus and its complications,\ncancer, ischemia, inflammation, central nervous system disorders, cardiovascular disease,\nAlzheimer's disease, dermatological disease, virus diseases, inflammatory disorders, or\ndiseases in which the liver is a target organ.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867330666230531164754","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T09:59:57Z","timestamp":1685613597000},"page":"1036-1039","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Novel Pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazoles as Protein\nKinase C Inhibitors for Treating Diseases"],"prefix":"10.2174","volume":"31","author":[{"given":"Surya K.","family":"De","sequence":"first","affiliation":[{"name":"Conju-probe, San Diego, California, USA"},{"name":"Department of Chemistry, Bharath University, Chennai, Tamil\nNadu, 600126, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"109071","DOI":"10.1016\/j.clim.2022.109071","volume":"241","author":"Sipka S.","year":"2022","unstructured":"Sipka S.; B\u00edr\u00f3 T.; Czifra G.; Griger Z.; Gergely P.; Brug\u00f3s B.; Tarr T.; The role of protein kinase C isoenzymes in the pathogenesis of human autoimmune diseases. Clin Immunol 2022,241,109071","journal-title":"Clin Immunol"},{"key":"ref=2","author":"Li H.","year":"2014","unstructured":"Li H.; Nukui S.; Scales S.A.; Teng M.; Yin C.; Npyrimidin- 4-yl-3-amino-pyrrolo[3,4-c]pyrazole derivatives as PKC kinase inhibitors. US Patent, US8877761B2, 2014"},{"key":"ref=3","author":"Botrous I.","year":"2016","unstructured":"Botrous I.; Hong Y.; Li H.; Liu K.K.C.; Nukui S.; Teng M.; 3-amido-pyrrolo[3,4-c]pyrazole-5(1h, 4h,6h) carbaldehyde derivatives as inhibitors of protein kinase c. European Patent, EP2195321B1, 2016"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"eabo0264","DOI":"10.1126\/scisignal.abo0264","volume":"15","author":"Cooke M.","year":"2022","unstructured":"Cooke M.; Kazanietz M.G.; Overarching roles of diacylglycerol signaling in cancer development and antitumor immunity. Sci Signal 2022,15(729),eabo0264","journal-title":"Sci Signal"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.3390\/cancers14051104","volume":"14","author":"He S.","year":"2022","unstructured":"He S.; Li Q.; Huang Q.; Cheng J.; Targeting protein kinase C for cancer therapy. Cancers 2022,14(5),1104","journal-title":"Cancers"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"816369","DOI":"10.3389\/fcvm.2022.816369","volume":"9","author":"Miao L.","year":"2022","unstructured":"Miao L.; Pan D.; Shi J.; Du J.; Chen P.; Gao J.; Yu Y.; Shi D.Z.; Guo M.; Role and mechanism of PKC-\u03b4 for cardiovascular disease: Current status and perspective. Front Cardiovasc Med 2022,9,816369","journal-title":"Front Cardiovasc Med"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.3390\/pharmaceutics13111748","volume":"13","author":"Kawano T.","year":"2021","unstructured":"Kawano T.; Inokuchi J.; Eto M.; Murata M.; Kang J.H.; Activators and inhibitors of protein kinase C (PKC): Their applications in clinical trials. Pharmaceutics 2021,13(11),1748","journal-title":"Pharmaceutics"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/08820139.2020.1829638","volume":"51","author":"Sharifinejad N.","year":"2022","unstructured":"Sharifinejad N.; Azizi G.; Behniafard N.; Zaki-Dizaji M.; Jamee M.; Yazdani R.; Abolhassani H.; Aghamohammadi A.; Protein Kinase C-Delta defect in Autoimmune Lymphoproliferative syndrome-like disease: First case from the national iranian registry and review of the literature. Immunol Invest 2022,51(2),331-342","journal-title":"Immunol Invest"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"929510","DOI":"10.3389\/fcell.2022.929510","volume":"10","author":"Pilo C.A.","year":"2022","unstructured":"Pilo C.A.; Newton A.C.; Two sides of the same coin: Protein Kinase C \u03b2 in cancer and neurodegeneration. Front Cell Dev Biol 2022,10,929510","journal-title":"Front Cell Dev Biol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1101\/lm.038844.115","volume":"22","author":"Jalil S.J.","year":"2015","unstructured":"Jalil S.J.; Sacktor T.C.; Shouval H.Z.; Atypical PKCs in memory maintenance: The roles of feedback and redundancy. Learn Mem 2015,22(7),344-353","journal-title":"Learn Mem"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1007\/s11011-022-01041-1","volume":"37","author":"Kadir R.R.A.","year":"2022","unstructured":"Kadir R.R.A.; Alwjwaj M.; Bayraktutan U.; Protein kinase C-\u03b2 distinctly regulates blood-brain barrier-forming capacity of brain microvascular endothelial cells and outgrowth endothelial cells. Metab Brain Dis 2022,37(6),1815-1827","journal-title":"Metab Brain Dis"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"102813","DOI":"10.1016\/j.ebiom.2020.102813","volume":"56","author":"Zhao H.","year":"2020","unstructured":"Zhao H.; Gong L.; Wu S.; Jing T.; Xiao X.; Cui Y.; Xu H.; Lu H.; Tang Y.; Zhang J.; Zhou Q.; Ma D.; Li X.; The inhibition of Protein Kinase C\u03b2 contributes to the pathogenesis of preeclampsia by activating autophagy. EBioMedicine 2020,56,102813","journal-title":"EBioMedicine"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11224-022-02075-y","volume":"2022","author":"Starosyla S.A.","year":"2022","unstructured":"Starosyla S.A.; Volynets G.P.; Protopopov M.V.; Bdzhola V.G.; Pashevin D.O.; Polishchuk V.O.; Kozak T.O.; Stroi D.O.; Dosenko V.E.; Yarmoluk S.M.; Pharmacophore modeling, docking and molecular dynamics simulation for identification of novel human protein kinase C beta (PKC\u03b2) inhibitors. Struct Chem 2022,2022,1-15","journal-title":"Struct Chem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1038\/s41388-022-02179-z","volume":"41","author":"Melnyk J.E.","year":"2022","unstructured":"Melnyk J.E.; Steri V.; Nguyen H.G.; Hwang Y.C.; Gordan J.D.; Hann B.; Feng F.Y.; Shokat K.M.; Targeting a splicing-mediated drug resistance mechanism in prostate cancer by inhibiting transcriptional regulation by PKC\u03b21. Oncogene 2022,41(11),1536-1549","journal-title":"Oncogene"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"110228","DOI":"10.1016\/j.cellsig.2021.110228","volume":"91","author":"Renkhold L.","year":"2022","unstructured":"Renkhold L.; Kollmann R.; Inderwiedenstra\u00dfe L.; Kienitz M.C.; PKC-isoform specific regulation of receptor desensitization and KCNQ1\/KCNE1 K+ channel activity by mutant \u03b11B-adrenergic receptors. Cell Signal 2022,91,110228","journal-title":"Cell Signal"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1002\/stem.3352","volume":"39","author":"von Heydebrand F.","year":"2021","unstructured":"von Heydebrand F.; Fuchs M.; Kunz M.; Voelkl S.; Kremer A.N.; Oostendorp R.A.J.; Wilke J.; Leitges M.; Egle A.; Mackensen A.; Lutzny-Geier G.; Protein kinase C-\u03b2-dependent changes in the glucose metabolism of bone marrow stromal cells of chronic lymphocytic leukemia. Stem Cells 2021,39(6),819-830","journal-title":"Stem Cells"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"6044","DOI":"10.1038\/s41598-021-85344-w","volume":"11","author":"Berardi D.E.","year":"2021","unstructured":"Berardi D.E.; Ariza Bare\u00f1o L.; Amigo N.; Ca\u00f1onero L.; Pelagatti M.N.; Motter A.N.; Taruselli M.A.; D\u00edaz Bessone M.I.; Cirigliano S.M.; Edelstein A.; Peters M.G.; Diament M.; Urtreger A.J.; Todaro L.B.; All-trans retinoic acid and protein kinase C \u03b1\/\u03b21 inhibitor combined treatment targets cancer stem cells and impairs breast tumor progression. Sci Rep 2021,11(1),6044","journal-title":"Sci Rep"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.semcancer.2017.04.012","volume":"48","author":"Isakov N.","year":"2018","unstructured":"Isakov N.; Protein kinase C (PKC) isoforms in cancer, tumor promotion and tumor suppression. Semin Cancer Biol 2018,48,36-52","journal-title":"Semin Cancer Biol"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867330666230531164754","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/217508\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867330666230531164754","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T10:00:13Z","timestamp":1700128813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/217508\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867330666230531164754","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-03-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}